The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 4, 2001, Pages 530-536

  Schmidt, Bernhard M W ^a   Kusma, Matthias ^a   Feuring, Martin ^a   Wehling, Martin ^a   Timmer, Wolfgang E ^b   Neuh�user, Markus ^b   Bethke, Thomas ^b   Stuck, Boris A ^a   Hörmann, Karl ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b ALTANA PHARMA AG   (Germany)

Author keywords

Allergic rhinitis; Asthma; PDE4 inhibitors; Rhino manometry

Indexed keywords

PHOSPHODIESTERASE IV INHIBITOR; PLACEBO; ROFLUMILAST; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOTHERAPY; MACROPHAGE ACTIVATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINOMANOMETRY; RISK BENEFIT ANALYSIS; SEASONAL VARIATION;

EID: 0034780393     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.118596     Document Type: Article

References (35)

1. Economic outcomes for the treatment of allergic rhinitis
2. Epidemiology of seasonal and perennial rhinitis: Clinical presentation and medical history
3. The cellular response to human allergic mucosa to natural allergen exposure
4. Allergic rhinitis and asthma: How important is the link?
5. The natural course of allergic rhinitis during 12 years of follow-up
6. WHO position paper on allergen immunotherapy: Therapeutic vaccination for allergen diseases
7. 1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials
8. Phosphodiesterase 4 inhibitors and the treatment of asthma
9. Differential regulation of human monocyte-derived TNFα and IL-1β by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors
10. Suppression of anti-CD3-induced interleukin-4 and interleukin-5 release from splenocytes of Mesocestoides corti-infected BALB/c mice by phosphodiesterase 4 inhibitors
11. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: Synergism with prostanoids and salbutamol
12. Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes
13. Effects of a selective phosphodiesterase 4 inhibitor (CDP-840) in a leukotriene-dependent non-human primate model of allergic asthma
14. Theophylline and isoenzyme-selective phosphodiesterase inhibitors
15. Phosphodiesterase isozymes: Molecular targets for novel anti-asthmatic agents
16. Anti-inflammatory and immunomodulatory potential of the new PDE4 inhibitor roflumilast in vitro
17. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor
18. Multiple testing in clinical trials
19. The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis
20. Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils
21. Therapeutic potential of selective PDE inhibitors in asthma
22. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterase 3 and 4
23. Therapeutic potential of phosphodiesterase-4 and-3 inhibitors in Th1-mediated autoimmune diseases
24. Antagonists of cyclic nucleotide phosphodiesterase (PDE) isozymes PDE3 and PDE4 suppress lymphoblastic response to HLA class II alloantigens: A potential novel approach to preventing allograft rejection?
25. Phosphodiesterase type 4 inhibitors, but not glucocorticoids, are more potent in suppression of cytokine secretion by mononuclear cells from atopic than nonatopic donors
26. Once daily intranasal fluticasone propionate (200 mg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis
27. Effects of high doses of topical steroids on both ragweed and histamine induced nasal provocation
28. A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis
29. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber
30. Intranasal fluticasone propionate: A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis
31. Mometasone furoate. A review of its intranasal use in allergic rhinitis
32. Sensation of nasal airflow compared with nasal airway resistance in patients with rhinitis
33. Objective and subjective nasal airflow